Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Hair color production in mice is closely linked to the hair growth phase and may also influence hair growth itself.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Hair color production is closely linked to the active growth phase of hair in mice and may also influence hair growth itself.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Some medications can cause acne, and stopping these drugs is the main treatment.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Genomic approach finds new possible treatments for hair loss.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Ozone and procaine boost the release of healing factors in platelet-rich plasma.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Stem cell therapy shows promise for treating hair loss in androgenetic alopecia.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

Neuregulin3 affects cell development in the skin and mammary glands.

Keratin 15 expression in skin cells is regulated by two mechanisms involving PKC/AP-1 and FOXM1.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.